154 related articles for article (PubMed ID: 28327103)
1. Morphological and phenotypical features of ovarian metastases in breast cancer patients.
Peters IT; van der Steen MA; Huisman BW; Hilders CG; Smit VT; Vahrmeijer AL; Sier CF; Trimbos JB; Kuppen PJ
BMC Cancer; 2017 Mar; 17(1):206. PubMed ID: 28327103
[TBL] [Abstract][Full Text] [Related]
2. Identification of cell-surface markers for detecting breast cancer cells in ovarian tissue.
Peters IT; Hilders CG; Sier CF; Vahrmeijer AL; Smit VT; Baptist Trimbos J; Kuppen PJ
Arch Gynecol Obstet; 2016 Aug; 294(2):385-93. PubMed ID: 26946151
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Risk Factors of Ovarian Metastases in Breast Cancer Patients < 41 Years of Age in the Netherlands: A Nationwide Retrospective Cohort Study.
Peters IT; van Zwet EW; Smit VT; Liefers GJ; Kuppen PJ; Hilders CG; Trimbos JB
PLoS One; 2017; 12(1):e0168277. PubMed ID: 28125710
[TBL] [Abstract][Full Text] [Related]
4. New methods to improve the safety assessment of cryopreserved ovarian tissue for fertility preservation in breast cancer patients.
Rodríguez-Iglesias B; Novella-Maestre E; Herraiz S; Díaz-García C; Pellicer N; Pellicer A
Fertil Steril; 2015 Dec; 104(6):1493-502.e1-2. PubMed ID: 26364839
[TBL] [Abstract][Full Text] [Related]
5. Correlation of E-cadherin expression and routine immunohistochemistry panel in breast invasive ductal carcinoma.
Mohammadizadeh F; Ghasemibasir H; Rajabi P; Naimi A; Eftekhari A; Mesbah A
Cancer Biomark; 2009; 5(1):1-8. PubMed ID: 19242056
[TBL] [Abstract][Full Text] [Related]
6. Assessing the use of tumor-specific DARPin-toxin fusion proteins for ex vivo purging of cancer metastases from human ovarian cortex before autotransplantation.
Eijkenboom L; Palacio-Castañeda V; Groenman F; Braat D; Beerendonk C; Brock R; Verdurmen W; Peek R
F S Sci; 2021 Nov; 2(4):330-344. PubMed ID: 35559858
[TBL] [Abstract][Full Text] [Related]
7. Identifying Biomarkers in Lymph Node Metastases of Esophageal Adenocarcinoma for Tumor-Targeted Imaging.
de Gouw DJJM; Rijpkema M; de Bitter TJJ; Baart VM; Sier CFM; Hernot S; van Dam GM; Nagtegaal ID; Klarenbeek BR; Rosman C; van der Post RS
Mol Diagn Ther; 2020 Apr; 24(2):191-200. PubMed ID: 32048177
[TBL] [Abstract][Full Text] [Related]
8. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of quantitative polymerase chain reaction markers for the detection of breast cancer cells in ovarian tissue stored for fertility preservation.
Bockstaele L; Boulenouar S; Van Den Steen G; Dechène J; Tsepelidis S; Craciun L; Noël JC; Demeestere I
Fertil Steril; 2015 Aug; 104(2):410-7.e4. PubMed ID: 26048150
[TBL] [Abstract][Full Text] [Related]
10. Expression of cell adhesion molecules and prognosis in breast cancer.
Saadatmand S; de Kruijf EM; Sajet A; Dekker-Ensink NG; van Nes JG; Putter H; Smit VT; van de Velde CJ; Liefers GJ; Kuppen PJ
Br J Surg; 2013 Jan; 100(2):252-60. PubMed ID: 23175431
[TBL] [Abstract][Full Text] [Related]
11. Expression of candidate tumor markers in ovarian carcinoma and benign ovary: evidence for a link between epithelial phenotype and neoplasia.
Drapkin R; Crum CP; Hecht JL
Hum Pathol; 2004 Aug; 35(8):1014-21. PubMed ID: 15297969
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative imaging of metastatic lymph nodes using a fluorophore-conjugated antibody in a HER2/neu-expressing orthotopic breast cancer mouse model.
Wu J; Ma R; Cao H; Wang Z; Jing C; Sun Y; Zhang Y; Yang Z; Hoffman RM; Tang J
Anticancer Res; 2013 Feb; 33(2):419-24. PubMed ID: 23393332
[TBL] [Abstract][Full Text] [Related]
13. Searching for metastases in ovarian tissue before autotransplantation: a tailor-made approach.
Hoekman EJ; Smit VT; Fleming TP; Louwe LA; Fleuren GJ; Hilders CG
Fertil Steril; 2015 Feb; 103(2):469-77. PubMed ID: 25497447
[TBL] [Abstract][Full Text] [Related]
14. Expression of E-cadherin and c-erbB-2/HER-2/neu oncoprotein in high-grade breast cancer.
Turashvili G; Bouchalova K; Bouchal J; Kolar Z
Cesk Patol; 2007 Jul; 43(3):87-92. PubMed ID: 17821836
[TBL] [Abstract][Full Text] [Related]
15. Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
Harigopal M; Berger AJ; Camp RL; Rimm DL; Kluger HM
Clin Cancer Res; 2005 Jun; 11(11):4083-9. PubMed ID: 15930343
[TBL] [Abstract][Full Text] [Related]
16. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
Bostick PJ; Chatterjee S; Chi DD; Huynh KT; Giuliano AE; Cote R; Hoon DS
J Clin Oncol; 1998 Aug; 16(8):2632-40. PubMed ID: 9704713
[TBL] [Abstract][Full Text] [Related]
17. Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?
Falck AK; Fernö M; Bendahl PO; Rydén L
World J Surg; 2010 Jul; 34(7):1434-41. PubMed ID: 20213203
[TBL] [Abstract][Full Text] [Related]
18. A breast cancer cell microarray (CMA) as a rapid method to characterize candidate biomarkers.
Wu X; Zahari MS; Renuse S; Jacob HK; Sakamuri S; Singal M; Gabrielson E; Sukumar S; Pandey A
Cancer Biol Ther; 2014; 15(12):1593-9. PubMed ID: 25535895
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer.
Heinzelmann-Schwarz VA; Gardiner-Garden M; Henshall SM; Scurry J; Scolyer RA; Davies MJ; Heinzelmann M; Kalish LH; Bali A; Kench JG; Edwards LS; Vanden Bergh PM; Hacker NF; Sutherland RL; O'Brien PM
Clin Cancer Res; 2004 Jul; 10(13):4427-36. PubMed ID: 15240533
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients.
Aktas B; Kasimir-Bauer S; Müller V; Janni W; Fehm T; Wallwiener D; Pantel K; Tewes M;
BMC Cancer; 2016 Jul; 16():522. PubMed ID: 27456970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
